The primary outcome for LEADER, SUSTAIN-6, EXSCEL, HARMONY Outcomes, REWIND, PIONEER 6 and AMPLITUDE-O was a three-point MACE, whereas ELIXA used a four-point MACE, including also hospital admission for unstable angina
The company used its three-month head start on Lilly to shape the narrative and combat concerns that people wouldn't want a pill that needs to be taken first thing in the morning without food and with little water, which Novo CEO Mike Doustdar said were "a bit fueled by our competitor." "Well, I have news for you, this has been absolutely not the case," Doustdar told CNBC in March
These powerful tools offer a new path for many who struggle with obesity, but separating fact from fiction is crucial for a realistic and healthy approach
Lets look into how the urban lifestyle is speeding up this wear & tear
Pathophysiology of Obesity